A clinical-stage biopharmaceutical company focused on developing treatments for retinal diseases, particularly neovascular age-related macular degeneration (nAMD) through anti-VEGF therapies.
Berkeley Heights, NJ, United States~20 employeesFounded Jan 2019Website